Cargando…
Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liver Cancer (BCLC) staging system and prognosis of patients with hepatocellular carcinoma (HCC). We downloaded 4 gene expression datasets from the Gene Expression Omnibus database (http://www.ncbi.nlm.n...
Autores principales: | Xu, Wei, Rao, Quan, An, Yongbo, Li, Mengyi, Zhang, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107203/ https://www.ncbi.nlm.nih.gov/pubmed/30138346 http://dx.doi.org/10.1371/journal.pone.0202763 |
Ejemplares similares
-
Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)
por: Goswami, Pulak, et al.
Publicado: (2022) -
Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child–Pugh A liver function: A double-center study from China
por: Xu, Wei, et al.
Publicado: (2018) -
Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014) -
Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages
por: Guo, Hui, et al.
Publicado: (2018) -
Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
por: Zhang, Yue-Lin, et al.
Publicado: (2020)